BRD4 and breast cancer: The Western blotting (WB) result showed that BRD4 degradation was almost completely abolished by pre-treatment with the proteasome inhibitor MG-132, the E1 neddylation inhibitor MLN4924, and the BRD4 ligand, JQ1 in BC cells.